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Highlights 
 The six Argentinean BoHV4 strains analyzed infect cells of human origin 
 The lytic capacity of each strain has not direct association with viral titers  
 The dynamics of replication is independent of the genetic classification 
 The biological behavior would be mainly conditioned by the nature of the cells 
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ABSTRACT 
Bovine gammaherpesvirus 4 (BoHV4) is a member of the family Herpesviridae. In Argentina, 
BoHV4 was isolated and characterized in 2007 from samples of aborted cows. Argentinean 
isolates are highly divergent and are classified as: Genotype 1(Movar-like), Genotype 2 (DN599-
like) and Genotype 3 (a novel group). The aim of this study was to comparatively evaluate the 
biological characteristics of six Argentinean BoHV4 field isolates in cell lines from different 
origins. All strains induced productive infection in the cell lines used, with different degrees of 
permissiveness. A direct relationship among the times of appearance of cytopathic effect, the 
growth kinetics, the size of the lysis plaques and the virulent-like behaviour in vitro could not be 
established. However, although slight, there are differences in the biological behaviour of the 
BoHV4 fields isolates analyzed. This variability is independent of their genetic classification but 
would be conditioned by the nature of the infected cells.  
 
Keywords: BoHV4, Replicative properties,  In vitro characterization, Argentinean field isolates   
 
1. Introduction   
 Bovine gammaherpesvirus type 4 (BoHV4) is a member of the family Herpesviridae (order 
Herpesvirales), subfamily Gammaherpesvirinae. Initially considered as a cytomegalovirus, it was 
later classified within the genus Rhadinovirus according to the activity of the thymidine kinase 
and to genomic similarities with other viruses of this subgroup, as saimiriine herpesvirus 2 
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(SaHV2) [1], human herpesvirus 8 (HHV8 or Kaposi’s sarcoma virus) and murid herpesvirus 4 
(MuHV4). 
 BoHV4 has been isolated from cattle with respiratory infections, vulvovaginitis, mastitis, 
abortions, endometritis and apparently healthy animals throughout the world [2-8]. This virus has 
not yet been established as causal agent of a particular disease entity. However, it is primarily 
associated with reproductive disorders of cattle, particularly in the postpartum period [9].  
Unlike other gammaherpesviruses, BoHV4 can infect a wide range of domestic and wild ruminant 
species [10-16]. Likewise, this virus infects a variety of cells, including cell lines and primary cell 
cultures of bovine, ovine, caprine, canine, feline, porcine, rabbit and chicken, as well as several 
human cell lines [12, 17-19]. Furthermore, it has been shown that human cell lines from lymphoid 
and myeloid origins were resistant to BoHV4, and epithelial and carcinoma cells were sensitive 
[20]. 
 It has been previously reported that BoHV4 presents genomic variations. By genetic studies 
of American (DN599 and 66-p-347) and European (V test, Movar and LVR140) reference strains 
groups, significant differences were identified in at least nine open reading frames (ORFs) [10, 21, 
22], including the presence or absence of sites for EcoRI and BamHI restriction enzymes and 
variations in the length of polyrepetitive DNA sequences (prDNA) [23]. In addition, variability 
among isolates from different regions has been observed, as well as emerging new strains, which 
restriction patterns do not fully match to the previously mentioned prototypes. This variability 
would be the result of recombination events among strains and within the same strain, mainly in 
prDNA sequences located on both sides of the long unique region (LUR) of the genome, during 
viral replication [7, 24-26].  
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 In Argentina, BoHV4 was isolated and characterized in 2007 from vaginal discharge 
samples of aborted cows [27]. Presently, more than 70 isolates have been identified in our country, 
mainly associated with abortions in bovine females. Genomic analyses of these Argentinean strains 
demonstrated that they are highly divergent and can be classified in three different groups: 
Genotype 1 comprises Movar-like strains (European group), Genotype 2 includes DN599-like 
strains (American group) and Genotype 3 corresponds to a novel genotype group [26]. Thereafter, 
the virus was isolated from nasal swabs, brain tissue, granulosa cells, oocytes [28] and bovine 
semen [29, 30]. 
 Determining the kinetics of viral replication is relevant for the in vitro characterization of 
viruses. Although information on the susceptibility of several cell lines to the infection by BoHV4 
is available [20], the in vitro behaviour of some Argentinean strains has been only analyzed on one 
cell lines from bovine origin [35]. Therefore, the aim of the present study was to comparatively 
evaluate the biological characteristics of six Argentinean BoHV4 field isolates in four cell lines 
from different origins.   
 Understanding the in vitro biological behaviour of these strains will contribute to 
characterize the BoHV4 field isolates in Argentina, and to improve the diagnosis of this virus from 
clinical specimens.   
 
 
2. Materials and methods 
2.1 Cell lines and culture conditions 
   A bovine (Madin-Darby Bovine Kidney, MDBK, [CCL-22]), two  human (HeLa [CCL-
2] and Hep2 [CCL-23]) and one simian (Vero [CCL-81]) cell lines from the American Type 
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Culture collection (ATCC, Rockville, MD, USA)  were used in this study. The cell cultures were 
propagated in Minimum Essential Medium (MEM, Sigma–Aldrich), supplemented with 10% 
inactivated and gamma irradiated fetal bovine serum (FBS) (Natocor - Córdoba, Argentina) free 
from viruses and antibodies, and with antibiotic solution including 100 µg/l penicillin (penicillin 
G sodium salt, Sigma-Aldrich) and 200 µg/l streptomycin (streptomycin sulphate, Sigma-Aldrich). 
Cells were incubated at 37 ◦C in a 5% CO2 atmosphere. 
 
2.2 Virus strains 
  Six BoHV4 strains, previously described by [26] were used in this study: 09/508 (genotype 
1), 08/330, 08/263, 12/365 (genotype 2), 07/435 and 09/227 (genotype 3). 
 All virus stocks were propagated in MDBK cells, in T-25 flasks (Greiner Bio-One, Germany) 
(2 × 105 cells/ml), for 48 h. Supernatants were harvested and frozen at −80 ◦C. Virus titers were 
determined by the endpoint titration method on MDBK cells in 96-well microtiter plates (Greiner 
Bio-One, Germany) and expressed as log10 TCID50/ml [31].  
 
2.3 Cell cultures infection and viral quantitation  
  Cell cultures were grown in 24-well plates (Greiner Bio-One, Germany) at a concentration 
of 2 × 105 cell/ml and infected with BoHV-4 strains at a multiplicity of infection (MOI) of 0.1. Virus 
was adsorbed for 1 h in the absence of serum, then monolayers were washed and fresh media (MEM, 
10% FBS) was added. Virus replication was evaluated after infection of a preformed, confluent 
monolayer with 24 h of growth. Cells were incubated at 37 ◦C with 5% CO2 and observed daily for 
the presence of cytopathic effect (CPE). The supernatants were harvested at 24, 48, 72, 96 and 120 
hours post-infection (hpi) and frozen at −80 ◦C for further viral quantitation of extracellular 
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fractions. At the time of supernatant collection, the evidence of CPE was recorded; the cells were 
harvested with trypsin-EDTA and stored at −80 ◦C for subsequent DNA extraction and viral genome 
detection. Virus titers were determined as previously described, in 96-well plates (Greiner Bio-One, 
Germany). All assays were performed by triplicate. Appropriate negative controls (mock-infected 
cells) were included in each experiment. 
 
2.4 Detection of BoHV4 DNA by nested PCR 
    BoHV4-infected- and mock-infected cells were harvested and DNA was extracted by the 
phenol-chloroform method. DNA concentration was determined by spectrophotometry in a Nano 
Drop 2000 (Thermo Scientific - USA) at an absorbance of 260 nm.  
The presence of BoHV4 DNA was evaluated by a nested PCR assay adapted from [33] targeting 
ORF 25 (major capside protein) of the viral genome. The PCR amplifications were carried out in 
25 µl reaction mixture containing 1 µl of 5 mM deoxynucleotide triphosphates (Promega), 1µl of 
15 pmol primers, 1.25 µl of 50 mM MgCl2 ( PB-L, Argentina);  0.25 µl of  5U/µl Taq DNA 
polymerase (PB-L, Argentina), 2.5 µl of 10 x buffer (PB-L, Argentina) and water. For the second 
amplification round, 2 µl of the first round PCR product were used. The primers used for the 
amplifications were BoG3 5’GACTATGAGGAATGGCACAAG 3’ and BoGe 
5’TACTCGTAGGCTGGGTCTGG3’ in the first round, and B4up 
5’GGTTGGAAGTGAGCGTATGAT3’ and B4 low 5’GTAGGCGGGGTCTGGAAT 3’ in the 
second (Invitrogen). The PCR products were 737 bp and 271 bp for the first and the second round, 
respectively. The amplifications were carried out in a Veriti Thermal Cycler (Applied Biosystem 
- USA) as follows: first round consisted of 94 ◦C 15 min; [94◦C 45 s; 56◦C 45 s; 72◦C 90 s] for 25 
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cycles. The second amplification round was [94 ◦C 45 s; 56◦C 45 s; 72◦C 60 s] for 30 cycles and 
one extension cycle at 72◦C for 10 min.   
 As negative control DNA from each mock-infected cell line was used. DNA from the cell 
lines infected with each viral strain was used as positive control. The PCR products were separated 
by electrophoresis in 1.2% agarose gels stained with SYBR® Safe DNA gel stain (Thermofisher, 
Argentina) and visualized under ultraviolet light. 
 
 2.5 Lysis plaques assay 
    Cell cultures were grown in triplicate in 6-well plates (Greiner Bio-One, Germany) at a 
concentration of 2 × 105 cell/ml, infected with the BoHV4 strains at an MOI of 0.1 and incubated 
for 1 h. The virus inoculum was removed and 2 ml of the overlay medium (0.6% low-melting point 
agarose, MEM and 10% FBS) pre-warmed at 60 ᵒC, was added to each well. The infected- and 
mock-infected- cell monolayers were incubated at 37 ᵒC in 5% CO2 for 72 h. After removing the 
solidified overlay, the monolayers were fixed and stained with 1% crystal violet solution and 
recorded. Then, 10 plaques per well were randomly selected and measured. The average size of 
the plaques (mm) was calculated and data were statistically analyzed.  
 
2.6 Statistical analysis 
    The experimental design for determination of the replication kinetics consisted of divided 
plots with repeated measurements over time. The main plot included the effect of the virus with 3 
replicates. The measurements were repeated at the previously indicated time-points. A comparison 
of least-square means was carried out using Tukey–Kramer’s test. The MIXED procedure of SAS 
was used. The GLM procedure of SAS was used to analyze the variance [32]. 
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3. Results 
3.1 Kinetics of replication of Argentinean BoHV4 field isolates 
   As a first step to determine if there are differences in virus infectivity among the six BoHV4 
strains, virus titers in cell cultures were evaluated at different time-points (Table 1). 
In general, the analysis of the kinetics of growth of BoHV4 strains in cell cultures of different 
origin revealed that strain 08/330 replicated better in all cell lines. Virus titers were significantly 
higher (p ≤ 0.05) (5 to 9 log) for 08/330 strain when compared to the remaining strains, with the 
highest titers detected at 48 hpi (Fig. 1b). Growth kinetics was highly variable for the other five 
strains in Hela and Hep2 cells when compared to their replication in MDBK and Vero cell lines. 
It was observed a greater homogeneity in the growth kinetics of 09/508 and 08/330 strains in the 
four cell lines, maintaining virus titers ranging from 2 to 4.5 and 5 to 9 log, respectively (Figs. 1a-
b). Virus production in the extracellular fraction was not detected at 24 hpi for strain 12/365 in any 
of the cell lines (Fig. 1d). Similar results were obtained for strains 08/263 and 07/435 in Vero and 
HeLa cells, and for 09/227 in HeLa cells (Figs. 2c-d).   
 In MDBK cells, strains 12/365 and 09/227 showed similar dynamics of replication, 
reaching the highest titers at 96 hpi. Strains 07/435 and 08/263 displayed the same growth kinetics, 
with the highest titers detected between 48 and 72 hpi. Strain 09/508 showed a constant decline 
from 24 hpi to 120 hpi (Fig. 2a). 
 In Hep2 cells, average titers for all strains were 4 to 4.5 log, with non-significant 
differences detected for strains 09/508, 08/263 and 07/435 (p >0.05). For strains 12/365 and 
09/227, viral titers in this cell line were significantly lower (2 to 3 log) with respect to the other 
strains (p <0.05) (Fig. 2b). 
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Viral titers in Vero cells were 2 to 4 log and there were no significant differences for strains 07/435, 
08/263 and 12/365 (p > 0.05) and for strains 09/508 and 09/227 (p > 0.05) (Fig. 2c). 
In HeLa cells, medium values (4 to 4.5 log) were recorded for strains 09/508 and 08/263 at 48 hpi, 
gradually declining until 120 hpi. The lowest values, 2 to 2.5 log, were observed for strains 07/435, 
09/227 and 12/365 (Fig. 2d). 
 
3.2 Detection of the genome of BoHV4 strains and cytopathic effect in the different cell cultures 
   Viral DNA for all strains was detected from 24 hpi in the four cell lines, except for strain 
08/330 in MDBK and 09/508 in Hep2 cells. Viral genome was not detected after 72 hpi in HeLa 
and Vero cells for strains 07/435 and 08/330, respectively.     
In MDBK and Hep2 cultures most of the strains produced CPE between 24 and 48 hpi, whereas 
in HeLa and Vero CPE was evidenced at 72 hpi, except for 09/508 in HeLa and 08/263 in Vero 
(Table 2). 
 
 3.3 Plaque phenotype of BoHV4 strains  
    Plaques of lysis of BoHV4 strains were measured and they were classified according to 
the size as large (≥ 3 mm), medium (1-3 mm) and minimum (< 1 mm). Large plaques were not 
evident in any of the cell types. In general, the size of plaques in the infected cell lines varied from 
0.4 mm to 1.5 mm (Table 3). 
 Strains  09/227, 08/263 and 07/435 produced medium-sized plaques in MDBK cells (Fig. 
3a) and the size of these plaques was significantly greater  (p <0.05) with respect to the plaques 
produced by strains 08/330 and 12/365. On the contrary, these strains produced significantly 
greater plaques (p <0.05) than the remaining four strains in HeLa cells (Fig. 3b). 
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 In Hep2 cells, all the strains produced minimum plaques. In this cell line, strain 09/508 
produced significantly smaller plaques (p <0.05) (Fig. 3c). In Vero cells, the six strains produced 
minute plaques with significant difference (p <0.05) only detected for strains 08/330 and 07/435, 
which produced minute plaques of larger size than the other strains (Fig. 3d). 
Plaque size for strain 09/508 in MDBK and 09/227 in Hep2 cells could not be recorded since virus 
infection produced a total detachment of the cell monolayer at 72 hpi. 
 
4. Discussion  
 In contrast to other gammaherpesviruses, BoHV4 grows efficiently in different cell 
cultures [17, 18, 20, 34]. However, on the basis of the information provided by the literature it can 
be inferred that there is a wide range of differences in the biological properties of BoHV4; 
coincidently, a significant variation in the kinetics of replication of different BoHV4 local isolates 
has been previously reported by our research group [35].  
 In this work, it was evaluated the in vitro biological activity of six local field isolates of 
BoHV4. The study of the dynamics of replication has allowed us to obtain information about the 
moment at which the extracellular virus is detected and to estimate the probable time in which 
each strain completes its replicative cycle. 
 The comparison of the kinetics of replication in each cell line showed that the production 
and viral detection in the extracellular medium occurred early (24 hpi) for all the strains in MDBK 
and Hep2 cells, except for strain 12/365. In Vero, extracellular viral detection at 24 hpi was only 
possible for 50% of the strains (09/508, 08/330 and 09/227), while in HeLa the detection of 
extracellular virus was not achieved before 48 hpi for 70% of the strains (08/263, 12/365, 09/227 
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and 07/435). This could indicate that the viral replication cycle would be slower in HeLa and Vero 
cells than in MDBK and Hep2 for most of the strains.  
 Direct association was not observed between the time in which each strain completes its 
cycle of replication, and releases new viral particles to the extracellular medium, with the 
appearance of CPE. These parameters could only be associated for strain 12/365, since 
extracellular virions of this strain were not detected before 48 hpi and the CPE was observed at 72 
hpi in the four cell lines. 
 Regarding the susceptibility of the cell lines, the results show that the four lines are 
susceptible to the infection by strains of different genotype. Nevertheless, different degrees of 
permissiveness are evidenced depending on the strain. 
 According to the viral titers obtained in the extracellular fraction, viral production was 
markedly higher for strain 08/330 in the four cell lines. This data is in agreement with the results 
of a previous work [35]. Apparently, the four cell lines are highly permissive for strain 08/330, 
and the lines of human origin showed a variable degree of permissiveness, (intermediate to low), 
when compared with the five remaining strains. Coincidently, data from the literature indicate that 
HeLa cells are poorly permissive to the infection by BoHV4 [20]. 
 To study the phenotypic characteristics of these strains a lysis plaque assay was carried 
out. This is an important parameter for the in vitro characterization of viruses since it is a direct 
measure of the pathogenic potential of a virus, as well as an indirect measure of the greater or 
lesser release of virions to the extracellular medium and the production of infective viral particles 
[36]. 
 The lysis plaque assay was performed at a low MOI and using a semi-solid medium. Under 
these conditions, the release and dissemination by adsorption of the virions to the neighboring 
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cells, are difficult. Therefore, this technique allows the evaluation of another viral dissemination 
mechanism, such as cell-to-cell virus diffusion. 
 The observation and measurement of the lysis plaques produced by these strains in the four 
cell cultures showed wide variability, mainly among the cell lines. The lytic activity of the strains 
was lower in Hep2 and Vero cells, in which all strains produced lysis plaques smaller than 1 mm. 
In MDBK cells, the largest plaque size and the greatest variability among the strains was observed; 
while in Hela cells the behaviour of the strains was opposite to that observed in MDBK cells. The 
data obtained by this assay verify that there is not a direct association between the viral titers 
detected and the lytic capacity of each strain. 
 The six Argentinean BoHV4 strains analyzed had the capacity to induce productive 
infection in the cell lines used in this assay. There were differences in the times of appearance of 
CPE among the strains in relation to the cell cultures. However, it was not possible to establish a 
direct relationship among this parameter, the growth curves (viral titers), the size of the lysis 
plaques and the virulent-like behaviour in vitro, unlike characterization studies made with field 
isolates of other bovine herpesviruses [36-38].  Therefore, although viral isolation in cell culture 
is the gold standard method for diagnosis of a virus infection, the variability in the rate of 
replication and the presentation of CPE of the different viral strains could make this methodology 
difficult to perform. Then, the use of highly sensitive techniques, such as nested PCR, provides 
greater efficacy for the detection of the virus. 
 Because of the aforementioned and considering the importance of BoHV4 in Argentina in 
relation to reproductive losses, it is necessary to deepen the biological studies of this viral agent; 
the characterization of the field isolates will give rise to fundamental knowledge about the 
molecular aspects of the virus. The high genetic variability among the strains isolated in Argentina 
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highlights the significance of studying the role of this virus. Furthermore, although the genomic 
characterization of these strains is currently being expanded, in previous studies, synonymous and 
non-synonymous substitutions have been observed in the gB, gH and Tk genes of the strains 
analyzed in this work [26, 35]. 
 
5. Conclusions  
 The findings of this study suggest that, although slight, there are differences in the 
behavioural patterns of the BoHV4 strains used in this in vitro study and this variability in the 
dynamics of replication and biological behaviour is independent of their genetic classification but 
would be conditioned mainly by the nature of the infected cells. These findings provide an initial 
step to understand the biology of the Argentinean isolates of BoHV4.  
Considering that BoHV4 has been detected, as an emerging and concomitant agent in reproductive 
infections of cattle in our country, characterizing the in vitro replication kinetics and determining 
the time point after infection at which a viral strain has its maximal potential of replication is a 
relevant fact to establish differences among the behaviour of BoHV4 isolates in cell cultures, since 
it might contribute to the understanding of the pathogenic role of each strain in their natural host. 
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Figure legends 
 
Fig. 1 Growth kinetics of six Argentinean BoHV4 field isolates on MDBK, Hep2,Vero and HeLa 
cells. Average virus titers (log10 TCID50), of each strain in the four challenged cell lines, obtained 
at 24, 48, 72, 96 and 120 h after infection 
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Fig. 2 Growth kinetics of six Argentinean BoHV4 field isolates on MDBK, Hep2,Vero and HeLa 
cells. Average virus titers (log10 TCID50), of the six strains in each cell line, obtained at 24, 48, 72, 
96 and 120 h after infection 
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Fig. 3 Lysis plaque assay for six Argentinean BoHV4 field isolates on (a) MDBK, (b) HeLa, (c) 
Hep2 and (d) Vero cells 72h after infection. Different uppercase letters indicate statistically 
significant differences (p ≤ 0.05) between virus strains within each cell line 
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Table 1. BoHV4 titers (log10 TCID50/ml) at 24, 48, 72, 96 and 120 hpi on MDBK, Hep2, Vero and 
HeLa cell lines. The values correspond to the average of three replicates. Means and standard 
errors are shown. Upper case letters (A, B, C, D) indicate significant differences  among strains at 
each time (p < 0.05). 
Strain  Cell line  
24h 
 
48h 
hpi 
72h 
 
96h 
 
120h 
09/508 MDBK 3.90 (+ 0.27)A 3.68 (+ 0.47)B 3.72 (+ 0.54)B 3.38 (+ 0.46)B 3.19 (+ 0.45)AB 
Hep2 3.52 (+ 0.19)A 4.17 (+ 0.64)AB 4.02 (+ 0.51)AB 4.13 (+ 0.36)A 3.69 (+ 0.29)A 
Vero 1.97 (+ 0.06)B 2.15 (+ 0.08)C 2.31 (+ 0.19)C 2.35 (+ 0.48)C 2.46 (+ 0.25)B 
Hela 3.56 (+ 0.35)A 4.67 (+ 0.15)A 4.54 (+ 0.07)A 3.98 (+ 0.37)AB 3.50 (+ 0.36)A 
08/330 MDBK 7.59 (+ 0.77)A 8.94 (+ 0.33)AB 8.14 (+ 0.53)A 7.98 (+ 0.06)A 7.16(+ 0.27)A  
Hep2 7.15 (+ 0.68)A 8.55 (+ 0.44)B 7.35 (+ 0.32)B 6.37(+ 0.59)B 5.55 (+ 0.61)BC 
Vero 5.56 (+ 0.44)B 8.82 (+ 0.54)B 7.90 (+ 0.70)AB 7.46 (+ 0.55)A 6.15 (+ 0.44)B 
HeLa 6.21 (+ 1.29)B 9.57 (+ 1.67)A 7.76 (+ 1.16)AB 5.29 (+ 0.51)C 4.94 (+ 0.68)C 
08/263 MDBK 3.21 (+ 0.47)A 4.28 (+ 0.47)A 4.36 (+ 0.20)A 3.60 (+ 0.09)A 3.25 (+ 0.39)AB 
Hep2 3.17 (+ 0.10)A 4.44 (+ 0.65)A 4.24 (+ 0.40)A 4.23 (+ 0.30)A 3.80 (+ 0.17)A 
Vero 0.00 (+ 0.00)B 2.81 (+ 0.24)B 3.45 (+ 0.32)B 4.01 (+ 0.13)A 3.99 (+ 0.00)AB 
HeLa 0.00 (+ 0.00)B 3.93 (+ 0.31)A 4.09 (+ 0.36)AB 3.51 (+ 0.48)A 3.05 (+ 0.31)B 
12/365 
 
MDBK 0.00  (+0.00)A 3.16 (+ 0.66)A 3.93 (+ 0.18)A 4.50 (+ 0.33)A 4.14 (+ 0.42)A 
Hep2 0.00 (+ 0.00)A 2.07 (+ 0.98)B  2.13 (+ 0.14)C 1.99 (+ 0.05)C 1.94 (+ 0.01)B 
Vero 0.00 (+ 0.00)A 2.76 (+ 0.78)AB 2.97 (+ 1.05)B 3.69 (+ 0.99)B 3.44 (+ 0.29)A 
HeLa 0.00 (+ 0.00)A 0.00 (+ 0.00)C 2.23 (+ 0.24)C 2.10 (+ 0.17)C 1.94 (+ 0.06)B 
07/435 MDBK 3.21 (+ 0.33)A 4.24 (+ 0.33)A 4.09 (+ 0.18)A 4.09 (+ 0.44)A 3.63 (+ 0.15)A 
Hep2 2.48 (+ 0.50)B 3.23 (+ 0.40)B 4.10 (+ 0.53)A 4.73 (+ 0.13)A 4.00 (+ 0.10)A 
Vero 0.00 (+ 0.00)C 3.13 (+ 0.35)B 2.57 (+ 0.20)B 2.93 (+ 0.19)B 2.79 (+ 0.45)B 
HeLa 0.00  (+ 0.00)C 2.49 (+ 0.17)B 3.09 (+ 0.18)B 2.83 (+ 0.07)B 2.86 (+ 0.14)B 
09/227 MDBK 1.35 (+ 1.17)B 3.42 (+ 0.51)A 4.23 (+ 0.45)A 4.60 (+ 0.45)A 3.79 (+ 0.14)A 
Hep2 2.54 (+ 0.50)A 3.06 (+ 0.05)A 2.95 (+ 0.15)B 2.54 (+ 0.50)B 2.34 (+ 0.41)B 
Vero 1.99 (+ 0.051)AB 2.87 (+ 0.58)A 2.37 (+ 0.26)B 2.67 (+ 0.67)B 2.47 (+ 0.40)B 
HeLa 0.00 (+ 0.00)C 2.33 (+ 0.30)D 2.46 (+ 0.37)B 2.53 (+ 0.30)B 2.50 (+ 0.19)B 
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Table 2. Appearance of CPE in MDBK, HeLa, Hep and Vero cell lines according to the time after 
infection (hpi) with Argentinean BoHV4 field isolates. 
Cell line hpi    
09/508 
 
08/330 
Strain 
08/263 
 
12/365 
 
07/435 
 
09/227 
MDBK 24 hpi +  +  +  
48 hpi  +    + 
72 hpi    +   
HeLa 24 hpi       
48 hpi +      
72 hpi  + + + + + 
Hep2 24 hpi +  +    
48 hpi  +   +  
72 hpi    +  + 
Vero 24 hpi       
48 hpi   +    
72 hpi + +  + + + 
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Table 3.  Plaque phenotypes for six Argentinean BoHV4 field isolates on MDBK , HeLa, Hep2 
and Vero cells 72h after  infection: Large (≥ 3 mm), Medium (1-3 mm), Minute (<1 mm). 
Cell line Strain 
 09/508 08/330 08/263 12/365 07/435 09/227 
MDBK        * 0.93 + 0.17 
         C 
1.57 + 0.66 
       CD 
0.1 + 0 
     B 
1.83 + 0.24 
         D 
1.70 + 0.56 
         D 
HeLa 
 
0.72 + 0.3 
      AB 
1.35 + 0.07 
        C 
0.87 + 0.66 
        B 
1.32 + 0.02 
        C 
0.79 + 0.19 
       AB 
0.73 + 0.25 
       AB 
Hep2 
 
0.1 + 0 
      B 
0.63 + 0.37 
        C 
0.61 + 0.35 
        C 
0.73 + 0.27 
        C 
0.62 + 0.36 
        C 
       * 
Vero 
 
0.4 + 0 
     AB 
0.76 + 0.42 
       CD 
0.42 + 0.11 
        B 
0.46 + 0.15 
       BC 
0.9 + 0.38 
        D 
0.34 + 0.63 
       AB 
 
Values are average mm of the lysis plaque + SD (standard deviation).  
Different uppercase letters in the same line indicate statistically significant differences (p ≤ 0.05) 
between virus strains within each cell line. 
* Detachment of monolayer 
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